Abstract:Sarcoidosis is a multi-system disease of unknown etiology characterized by the formation of granulomas in various organs. It affects people of all ethnic backgrounds and occurs at any time of life but is more frequent in African Americans and Scandinavians and in adults between 30 and 50 years of age. Sarcoidosis can affect any organ with a frequency varying according to ethnicity, sex and age. Intrathoracic involvement occurs in 90% of patients with symmetrical bilateral hilar adenopathy and/or diffuse lung micronodules, mainly along the lymphatic structures which are the most affected system. Among extrapulmonary manifestations, skin lesions, uveitis, liver or splenic involvement, peripheral and abdominal lymphadenopathy and peripheral arthritis are the most frequent with a prevalence of 25–50%. Finally, cardiac and neurological manifestations which can be the initial manifestation of sarcoidosis, as can be bilateral parotitis, nasosinusal or laryngeal signs, hypercalcemia and renal dysfunction, affect less than 10% of patients. The diagnosis is not standardized but is based on three major criteria: a compatible clinical and/or radiological presentation, the histological evidence of non-necrotizing granulomatous inflammation in one or more tissues and the exclusion of alternative causes of granulomatous disease. Certain clinical features are considered to be highly specific of the disease (e.g., Löfgren’s syndrome, lupus pernio, Heerfordt’s syndrome) and do not require histological confirmation. New diagnostic guidelines were recently published. Specific clinical criteria have been developed for the diagnosis of cardiac, neurological and ocular sarcoidosis. This article focuses on the clinical presentation and the common differentials that need to be considered when appropriate.

Clinical management of pulmonary sarcoidosis

Imaging of Pulmonary Sarcoidosis—A Review

Sarcoidosis: A Clinical Overview from Symptoms to Diagnosis

Sarcoidosis: Causes, Diagnosis, Clinical Features, and Treatments

Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline

BTS Clinical Statement on pulmonary sarcoidosis

Recent advances in sarcoidosis

ERS clinical practice guidelines on treatment of sarcoidosis

Treatment of Granulomatous Inflammation in Pulmonary Sarcoidosis

Clinical Features Analysis of 84 Patients with Sarcoidosis

The current state-of-the-art in pharmacotherapy for pulmonary sarcoidosis

Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association

Sarcoidosis: A Review of the Guidelines and What's To Come

Role of Bronchoscopy in Diagnosis of Sarcoidosis

Clinical Analysis of 27 Patients with Pulmonary Sarcoidosis

High-Risk Sarcoidosis: A Focus on Pulmonary, Cardiac, Hepatic and Renal Advanced Diseases, as Well as on Calcium Metabolism Abnormalities

How to Use and Monitor Sarcoidosis Medications

Diagnostic and management strategies in cardiac sarcoidosis

Five principles and protocols for the clinician based on the 2021 ERS and BTS statements for treating sarcoidosis

Cardiac Sarcoidosis—Diagnostic and Therapeutic Challenges

Atypical Computed Tomography Manifestations of Pulmonary Sarcoidosis